CRISM Therapeutics Corporation (AIM: CRTX)*: Phase II clinical trial progress updateAptamer Group plc (AIM: APTA): Programme and technical development updateAdvanced Medical Solutions Group plc (LSE: AMS): Agreement regarding recommended cash acquisition
25 Jun 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
Advanced Medical Solutions Group plc (AMS:LON), 279 | Aptamer Group Plc (APTA:LON), 0.6 | CRISM Therapeutics Corporation (CRTX:LON), 10.0
- Published:
25 Jun 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
4 -
CRISM Therapeutics Corporation (AIM: CRTX)*: Phase II clinical trial progress updateAptamer Group plc (AIM: APTA): Programme and technical development updateAdvanced Medical Solutions Group plc (LSE: AMS): Agreement regarding recommended cash acquisition